Eligibility required a body mass index (BMI) of 30 kg/m or higher, or for those with at least one obesity-related comorbidity and no diabetes, a BMI of 27 kg/m or higher
Who Should Not Use Sermorelin Like any growth hormone-stimulating therapy, Sermorelin is contraindicated in patients with active malignancy or a personal history of certain cancers, because anything that drives GH/IGF-1 production has theoretical risk in those settings
J., Hennig, U., & Fuchs, W
A consistent, well-tolerated single-medication protocol may produce better cumulative results over years than a cycling approach that maximizes short-term weight loss at the cost of repeated adjustment periods
Proportion of Obese Patients Presenting to Orthopedic Total Joint Arthroplasty Clinics
Some positive, long-term behavior and mood changes associated with a GLP-1 medication may include: Building healthy eating habits Eating more mindfully Becoming more physically active Being more aware of hunger and satiety (fullness) cues Increased confidence and increased self-esteem The feel-good loop that once came from indulging in chips, cookies, and other comfort foods can shift when you're on a GLP-1 medication